Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (521-530 of 575) with videos related to

Pageof 58
Sort By:
American Journal of Preventive Medicine|November 24, 2004
Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic reviewMona Saraiya, Karen Glanz, Peter A Briss, et al.
The Journal of Investigative Dermatology|December 21, 2020
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis-CorrectionCatherine H Smith, Satveer K Mahil, Zenas Z N Yiu, et al.
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trialPhilip Mease, Laura C Coates, Philip S Helliwell, et al.
RMD Open|February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITALLaura C Coates, Robert Landewé, Iain B McInnes, et al.
Annals of the Rheumatic Diseases|June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysisTommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
Critical Care (London, England)|November 28, 2017
High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trialKevin K Chung, Elsa C Coates, David J Smith, et al.
The British Journal of Dermatology|June 21, 2020
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysisS K Mahil, M C Ezejimofor, L S Exton, et al.
Seminars in Arthritis and Rheumatism|January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological studyYing-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Scientific Data|February 22, 2024
Ethnicity data resource in population-wide health records: completeness, coverage and granularity of diversityMarta Pineda-Moncusí, Freya Allery, Antonella Delmestri, et al.
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Pageof 58

Showing results (521-530 of 575) with videos related to

Sort By:
Pageof 58
American Journal of Preventive Medicine|November 24, 2004
Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic reviewMona Saraiya, Karen Glanz, Peter A Briss, et al.
The Journal of Investigative Dermatology|December 21, 2020
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis-CorrectionCatherine H Smith, Satveer K Mahil, Zenas Z N Yiu, et al.
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trialPhilip Mease, Laura C Coates, Philip S Helliwell, et al.
RMD Open|February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITALLaura C Coates, Robert Landewé, Iain B McInnes, et al.
Annals of the Rheumatic Diseases|June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysisTommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
Critical Care (London, England)|November 28, 2017
High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trialKevin K Chung, Elsa C Coates, David J Smith, et al.
The British Journal of Dermatology|June 21, 2020
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysisS K Mahil, M C Ezejimofor, L S Exton, et al.
Seminars in Arthritis and Rheumatism|January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological studyYing-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Scientific Data|February 22, 2024
Ethnicity data resource in population-wide health records: completeness, coverage and granularity of diversityMarta Pineda-Moncusí, Freya Allery, Antonella Delmestri, et al.
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Pageof 58